Asian Journal of Research and Reports in Endocrinology

Botanical Medicine for Organ Health in Diabetes Mellitus– Analysis of Clinical Outcome

G. V. Amruthavalli *

Dr JRK’s Research and Pharmaceuticals Pvt., Ltd, India.

Gayathri Rajagopal

Dr JRK’s Research and Pharmaceuticals Pvt., Ltd, India.

*Author to whom correspondence should be addressed.

---

Abstract

Diabetes is a metabolic disorder occurs due to insulin resistance or due to low production of insulin, this effects the glucose uptake by individual cells which progressively damages the cells or leads to improper functioning. These modifications at cellular levels progressively results in several co-morbidities. There are various medications available for blood glucose control not particular on cellular damages.

JRK’s D-Co-D tablets is a polyherbal medicine that is studied for its role in blood glucose control and organ health improvement. A three arm multi centered clinical observations and outcome are collected for three groups.

Blood glucose related and other organ health indicative parameters against the prescription of JRK’s D-Co-D tablets, a proprietary Siddha drug as an adjuvant to conventional therapy (Metformin +Vildagliptin) was analyzed.  Conventional line of therapy without JRK’s D-Co-D tablets and Madhumeghachoornam instead of JRK’s D-Co-D tablets were kept as control groups. 

Blood glucose related and other parameters (blood and urine) post inclusion of JRK’s D-Co-D tablets as an adjuvant was shown a remarkable improvement when compared to other two groups.  Statistical significance was also established for the above findings. The treatment inclusion of JRK’s D-Co-D tablets clearly indicated significant improvement of various vital organs (functioning) and confirms the role of JRK’s D-Co-D tablets to prevent co-morbidity associated with diabetes mellitus.

Keywords: D-co-D tablets, JRK’s, diabetic complications, siddha medicine, complications of diabetes, co-morbidities of diabetes, blood and urine test in diabetes

---

---

---

References

Tripathy JP. Burden and risk factors of diabetes and hyperglycemia in India: findings from the Global Burden of Disease Study 2016. Diabetes MetabSyndrObes. 2018;11:381-387.

Asif M. The prevention and control the type-2 diabetes by changing lifestyle and dietary pattern. J Educ Health Promot. 2014;21;3:1. DOI: 10.4103/2277-9531.127541. PMID: 24741641; PMCID: PMC3977406.

Beulens JWJ, Pinho MGM, Abreu TC, et al. Environmental risk factors of type 2 diabetes—an exposome approach. Diabetologia 2022;65:263–274. Available:https://doi.org/10.1007/s00125-021-05618-w

Nathan DM, Buse JB, Davidson MB, Ferrannini E, Holman RR, Sherwin R, Zinman B. American Diabetes Association; European Association for study of diabetes. Medical management of hyperglycemia in type 2 diabetes: a consensus algorithm for the initiation and adjustment of therapy: a consensus statement of the American Diabetes Association and the European Association for the Study of Diabetes. Diabetes Care. 2009;32(1):193-203.

DOI: 10.2337/dc08-9025. Epub 2008 Oct 22. PMID: 18945920; PMCID: PMC2606813.

Foley PJ. Effect of low carbohydrate diets on insulin resistance and the metabolic syndrome. CurrOpinEndocrinol Diabetes Obes. 2021;28(5):463-468. DOI: 10.1097/MED.0000000000000659. PMID: 34468401; PMCID:

PMC8500369.

Aruna V, Amruthavalli GV, Gayathri R. Cellular level catalysation of glucose by organ level cells as a possible therapeutic scope for diabetes mellitus. International Journal of Science & Healthcare Research. 2021;6(1):166-171.

Amruthavalli GV, et al. Therapeutic polymorphism’ of anti-diabetic herbal drug. EC Diabetes and Metabolic Research 5. 2021;3:22-31.

Soundharya R, Aruna V, Amruthavalli GV, Gayathri Rajagopal. Comparison on the anti-diabetic effect of NIKU plus versus madhumegachooranam. Research & Reviews: A Journal of Unani, Siddha and Homeopathy. 2021;6(2).

Amruthavalli GV, Aruna.V, Gayathri Rajagopal. Solution for diabetes mellitus-niku plus. Journal of Diabetes and Treatment. 2019;02.

Amruthavalli GV, Gayathri R. Cause-consequence correction by JRK’s D-Co-D tablets in diabetes mellitus. International Research Journal of Pharmacy and Medical Sciences (IRJPMS). 2021;5(1): 1-3.

Saravana Babu C, Sathiya S, Anbarasi C, Prathyusha N, Ramakrishnan G, Kalaivani P, Jyothi Priya R, Selvarajan Kesavanarayanan K, Verammal Mahadevan M, Thanikachalam S. Polyphenols in madhumegachooranam, a Siddha medicine, ameliorates carbohydrate metabolism and oxidative stress in type II diabetic rats. J Ethnopharmacol. 2012;142(2):331-6. DOI: 10.1016/j.jep.2012.04.003. Epub 2012 May 23. PMID: 22633981.

Kennelty KA, Witry MJ, Gehring M, Dattalo M, Rogus-Pulia N. A four-phase approach for systematically collecting data and measuring medication discrepancies when patients transition between health care settings. Res Social Adm Pharm. 2016; 12(4):548-58.

DOI: 10.1016/j.sapharm.2015.09.001. Epub 2015 Sep 12. PMID: 26781670; PMCID: PMC4846572.

Pakkir Maideen NM, Jumale A, Balasubramaniam R. Drug Interactions of Metformin Involving Drug Transporter Proteins. Adv Pharm Bull. 2017.;7(4): 501-505.

DOI: 10.15171/apb.2017.062. Epub 2017 Dec 31. PMID: 29399540; PMCID: PMC5788205.

Altoum AEA, Abbas MY, Osman AL, Ahmed S, Babker AM. The influence of oral multivitamins supplementation on selected oxidative stress parameters and lipid profiles among sudanese patients with type-2 diabetes. Open Access Maced J Med Sci. 2019;25;7(5): 775-778. DOI: 10.3889/oamjms.2019.137

PMID: 30962837; PMCID: PMC6447348.